Key Takeaways
- • Blackstone, Apollo and Pimco are among private capital managers targeting capital that European insurers will free up as the EU eases insurance rules, according to AMWatch.
- • The story was published 18 November 2026 by AMWatch journalist Jens-Emil Grau Nørgaard; the full article is available only to subscribers, so the detail below is limited to the publicly visible headline and standfirst.
- • The regulatory change reduces capital constraints on European insurers, opening a larger pool of assets for alternative asset managers seeking long-duration capital.
- • Related AMWatch coverage points to parallel pressure in private credit, including rising loan stress and shrinking portfolios, which bears on how allocators weigh insurance-sourced capital.
Summary
The core dynamic is that looser regulatory treatment of insurers' capital requirements frees balance sheet capacity that insurers can deploy into higher-yielding assets. Private credit, infrastructure debt and other illiquid strategies are typically well suited to insurers' long-dated liabilities, which is why managers with dedicated insurance mandates have been active in the segment. The full article, which is behind a subscriber paywall, is expected to provide further detail on specific mandates and volumes; those figures are not available in the material reviewed here.
AMWatch's related coverage provides context for the environment in which these flows would occur. A separate story notes that Blackstone has increased lock-up periods for Asian investors, and another reports rising loan stress and shrinking portfolios across private credit funds. Together these pieces suggest that managers are seeking stable, long-term capital at a time when liquidity terms and credit quality are under scrutiny.
For institutional allocators and insurance investment teams, the development signals potential changes in competition for private-market deals and in how European insurers allocate across public and private assets. Readers seeking quantified fund-level figures or the specific regulatory provisions involved should consult the full AMWatch article.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.